Literature DB >> 33588899

GABAergic neuron-specific whole-brain transduction by AAV-PHP.B incorporated with a new GAD65 promoter.

Chiaki Hoshino1, Ayumu Konno1,2, Nobutake Hosoi1, Ryosuke Kaneko3,4, Ryo Mukai5, Junichi Nakai6, Hirokazu Hirai7,8.   

Abstract

GABAergic interneurons play a critical role in tuning neural networks in the central nervous system, and their defects are associated with neuropsychiatric disorders. Currently, the mDlx enhancer is solely used for adeno-associated virus (AAV) vector-mediated transgene delivery into cortical interneurons. Here, we developed a new inhibitory neuron-specific promoter (designated as the mGAD65 promoter), with a length of 2.5 kb, from a mouse genome upstream of exon 1 of the Gad2 gene encoding glutamic acid decarboxylase (GAD) 65. Intravenous infusion of blood-brain barrier-penetrating AAV-PHP.B expressing an enhanced green fluorescent protein under the control of the mGAD65 promoter transduced the whole brain in an inhibitory neuron-specific manner. The specificity and efficiency of the mGAD65 promoter for GABAergic interneurons, which was assessed at the motor cortex, were almost identical to or slightly higher than those of the mDlx enhancer. Immunohistochemical analysis revealed that the mGAD65 promoter preferentially transduced parvalbumin (PV)-expressing interneurons. Notably, the mGAD65 promoter transduced chandelier cells more efficiently than the mDlx enhancer and robustly labeled their synaptic boutons, called the cartridge, targeting the axon initial segments of excitatory pyramidal neurons. To test the ability of the mGAD65 promoter to express a functional molecule, we virally expressed G-CaMP, a fluorescent Ca2+ indicator, in the motor cortex, and this enabled us to monitor spontaneous and drug-induced Ca2+ activity in GABAergic inhibitory neurons. These results suggest that the mGAD65 promoter is useful for AAV-mediated targeting and manipulation of GABAergic neurons with the dominance of cortical PV-expressing neurons, including chandelier cells.

Entities:  

Keywords:  AAV; AAV-PHP.B; Chandelier cell; Dlx; GABA; GAD65; Inhibitory neuron; Interneuron; Promoter

Year:  2021        PMID: 33588899      PMCID: PMC7885384          DOI: 10.1186/s13041-021-00746-1

Source DB:  PubMed          Journal:  Mol Brain        ISSN: 1756-6606            Impact factor:   4.041


  5 in total

1.  Viral strategies for targeting spinal neuronal subtypes in adult wild-type rodents.

Authors:  Jaspreet Kaur; Rune W Berg
Journal:  Sci Rep       Date:  2022-05-23       Impact factor: 4.996

2.  Bidirectional Optogenetic Modulation of the Subthalamic Nucleus in a Rodent Model of Parkinson's Disease.

Authors:  Caroline Xie; John Power; Asheeta A Prasad
Journal:  Front Neurosci       Date:  2022-05-17       Impact factor: 5.152

Review 3.  AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System.

Authors:  Marika Marino; Matthew G Holt
Journal:  Front Neurol       Date:  2022-04-12       Impact factor: 4.086

4.  The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency.

Authors:  Ryota Nakahama; Aika Saito; Sensho Nobe; Kazuya Togashi; Ikuo K Suzuki; Akira Uematsu; Kazuo Emoto
Journal:  Mol Brain       Date:  2022-08-08       Impact factor: 4.399

5.  Selective transduction of cerebellar Purkinje and granule neurons using delivery of AAV-PHP.eB and AAVrh10 vectors at axonal terminal locations.

Authors:  Magdalena Surdyka; Ewelina Jesion; Anna Niewiadomska-Cimicka; Yvon Trottier; Żaneta Kalinowska-Pośka; Maciej Figiel
Journal:  Front Mol Neurosci       Date:  2022-09-13       Impact factor: 6.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.